It is on 2.4 hectares of land, in the heart of the Paris-Saclay campus, that the new Servier R&D center, designed by Jean-Michel Wilmotte, will be erected in early 2023.
Around the site, halfway through, half a dozen cranes: by 2024, a Danone R&D center, the Bio-Pharma-Chimie school and the Paris-Saclay hospital will emerge from the ground.
CentraleSupélec and L'École normale supérieure, heavyweights in maths and artificial intelligence, have already taken up residence there.
With 146 start-ups, large companies (Sanofi, GE Healthcare, etc.) and 15,000 jobs, the health and biotech sector is one of the most represented in Paris-Saclay.
15% of French research is based there.
Read also:
Ten years after the Mediator affair, Servier continues to evolve
"We made a strong choice, that of joining an open innovation system (innovation open to the outside, with partnerships, etc.),
explains Claude Bertrand, head of R&D at Servier, whose 1,500 employees in his department are currently spread over four sites in France.
Discovery
This article is for subscribers only.
You have 69% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in